Predominant drug-resistant mutations at reverse transcriptase (RT) genes have been M184V, T215Y, M41L and V108I and H221Y when at protease (PR) genes were M46I and I47V. Among the superior-risk teams, IDUs have the highest range of drug-resistant mutations accompanied by heterosexual persons. It had been further proven that drug-resistant mutations